GMP production of active pharmaceutical ingredients

BIOMEVA's facility is dedicated to the large-scale manufacturing of APIs expressed in microbial systems. Recombinant material on a clinical and commercial scale can be produced in batches up to 1000 L working volume.

Production and purification systems include:

• Fermenters with working volumes of 10 L, 100 L and 1000 L
• Continuous centrifugation
• High-pressure homogenization
• Protein micro-filtration and ultra-filtration
• Sterile filtration
• Column chromatography
• Bulk drug substance filling